ZA200401365B - Novel dihydropteridinones, method for producing the same and the use thereof as medicaments. - Google Patents

Novel dihydropteridinones, method for producing the same and the use thereof as medicaments.

Info

Publication number
ZA200401365B
ZA200401365B ZA200401365A ZA200401365A ZA200401365B ZA 200401365 B ZA200401365 B ZA 200401365B ZA 200401365 A ZA200401365 A ZA 200401365A ZA 200401365 A ZA200401365 A ZA 200401365A ZA 200401365 B ZA200401365 B ZA 200401365B
Authority
ZA
South Africa
Prior art keywords
medicaments
producing
same
use
method
Prior art date
Application number
ZA200401365A
Inventor
Matthias Hoffmann
Steffen Breitfelder
Gerald Pohl
Norbert Redemann
Martin Steegmaier
Jens Juergen Quant
Matthias Grauert
Christian Eickmeier
Thorsten Lehmann-Lintz
Gisela Schnapp
Eckhart Bauer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE10143272 priority Critical
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ZA200401365B publication Critical patent/ZA200401365B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
ZA200401365A 2001-09-04 2004-02-19 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments. ZA200401365B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10143272 2001-09-04

Publications (1)

Publication Number Publication Date
ZA200401365B true ZA200401365B (en) 2005-05-27

Family

ID=7697637

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200401365A ZA200401365B (en) 2001-09-04 2004-02-19 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments.

Country Status (29)

Country Link
EP (1) EP1427730B1 (en)
JP (1) JP3876254B2 (en)
KR (1) KR100955589B1 (en)
CN (1) CN1551881A (en)
AR (1) AR036586A1 (en)
AT (1) AT332898T (en)
AU (1) AU2002337047B2 (en)
BR (1) BRPI0212137A2 (en)
CA (1) CA2458699C (en)
CO (1) CO5560575A2 (en)
DE (1) DE50207522D1 (en)
DK (1) DK1427730T3 (en)
EA (1) EA007062B1 (en)
EC (1) ECSP045003A (en)
ES (1) ES2268093T3 (en)
HR (1) HRP20040213A2 (en)
HU (1) HU0401293A3 (en)
IL (2) IL160440D0 (en)
MX (1) MXPA04002067A (en)
MY (1) MY129751A (en)
NO (1) NO328804B1 (en)
NZ (1) NZ531928A (en)
PL (1) PL369740A1 (en)
PT (1) PT1427730E (en)
RS (1) RS51012B (en)
UA (1) UA76512C2 (en)
UY (1) UY27427A1 (en)
WO (1) WO2003020722A1 (en)
ZA (1) ZA200401365B (en)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516610A (en) 1999-08-04 2004-05-28 Icagen Inc Benzanilides as potassium channel openers
US6495550B2 (en) * 1999-08-04 2002-12-17 Icagen, Inc. Pyridine-substituted benzanilides as potassium ion channel openers
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
MXPA05009068A (en) * 2003-02-26 2005-10-19 Boehringer Ingelheim Pharma Dihydropteridinones, method for the production and use thereof in the form of drugs.
DE102004029784A1 (en) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel 2-Benzylaminodihydropteridinones, process for their preparation and their use as medicaments
DE102004033670A1 (en) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg New pyridodihydropyrazinone, process for its preparation and its use as a medicament
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
EP1630163A1 (en) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinones, methods for their preparation and their use as drugs
EP1632493A1 (en) 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridine derivatives, methods for their preparation and their use as drugs
WO2006021548A1 (en) * 2004-08-27 2006-03-02 Boehringer Ingelheim International Gmbh Dihydropteridinones, method for the production thereof, and use thereof as a medicament
DE102004058337A1 (en) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of fused piperazin-2-one derivatives
EP1915155A1 (en) * 2005-08-03 2008-04-30 Boehringer Ingelheim International GmbH Dihydropteridinones in the treatment of respiratory diseases
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
CA2652648C (en) 2006-02-14 2016-10-25 Vertex Pharmaceuticals Incorporated Dihydrodiazepines useful as inhibitors of protein kinases
JP2009537500A (en) * 2006-05-19 2009-10-29 アストラゼネカ アクチボラグ Dihydropteridine compounds as growth inhibitors
TW200808325A (en) * 2006-07-06 2008-02-16 Astrazeneca Ab Novel compounds
WO2008009909A1 (en) * 2006-07-17 2008-01-24 Astrazeneca Ab Pteridimones as modulators of polo-like kinase
WO2008040951A1 (en) * 2006-10-03 2008-04-10 Astrazeneca Ab Compounds
MX2009004077A (en) * 2006-10-19 2009-05-05 Signal Pharm Llc Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors.
EP1953163A1 (en) * 2007-02-01 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Pteridinone derivatives as PI3-kinases inhibitors
ES2371832T3 (en) * 2007-03-22 2012-01-10 Takeda Pharmaceutical Company Limited Pyrimidodiazepinas replaced useful as inhibitors of plk1.
WO2008157235A1 (en) * 2007-06-13 2008-12-24 University Of Virginia Patent Foundation Rsk inhibitors as anti-septicemia agents
JP5261487B2 (en) 2007-08-03 2013-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Crystal forms of dihydropteridinone derivatives
US8461149B2 (en) * 2007-08-15 2013-06-11 Vertex Pharmaceuticals Incorporated Compounds useful as protein kinase inhibitors
US8026234B2 (en) 2007-09-25 2011-09-27 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
WO2009071480A2 (en) * 2007-12-04 2009-06-11 Nerviano Medical Sciences S.R.L. Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
JP5593234B2 (en) 2008-03-11 2014-09-17 ユニバーシティー ヘルス ネットワーク Methods of treating cancer using neuropeptide Y5R (NPY5R) antagonists
EP2100894A1 (en) 2008-03-12 2009-09-16 4Sc Ag Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
EP2112152A1 (en) 2008-04-22 2009-10-28 GPC Biotech AG Dihydropteridinones as Plk Inhibitors
GB0807452D0 (en) * 2008-04-24 2008-05-28 Chroma Therapeutics Ltd PLK inhibitors
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
WO2009153197A1 (en) 2008-06-18 2009-12-23 F. Hoffmann-La Roche Ag Halo-substituted pyrimidodiazepines as plkl inhibitors
US8110578B2 (en) 2008-10-27 2012-02-07 Signal Pharmaceuticals, Llc Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
BRPI0923305B1 (en) 2008-12-09 2019-01-22 Gilead Sciences Inc toll-like receptor modulators, their use and pharmaceutical composition comprising them
PL2477987T3 (en) 2009-09-14 2018-06-29 Gilead Sciences, Inc. Modulators of toll-like receptors
CN102020643A (en) * 2009-09-22 2011-04-20 上海恒瑞医药有限公司 dihydropteridine ketone derivative, and preparation method and medicinal application thereof
CN103492391A (en) 2009-09-25 2014-01-01 沃泰克斯药物股份有限公司 Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
WO2011036566A1 (en) * 2009-09-25 2011-03-31 Vertex Pharmaceuticals Incorporated Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
CN106117213A (en) 2009-10-26 2016-11-16 西格诺药品有限公司 Heteroaryl compound and synthesis thereof and purification process
EP2325185A1 (en) 2009-10-28 2011-05-25 GPC Biotech AG Plk inhibitor
JP2013515734A (en) 2009-12-23 2013-05-09 エラン ファーマシューティカルズ,インコーポレイテッド Pteridinone as an inhibitor of polo-like kinases
US20120329803A1 (en) 2010-02-17 2012-12-27 Boehringer Ingelheim International Gmbh Dihydropteridinones, method for production and use thereof
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
MX357833B (en) 2011-10-19 2018-07-26 Signal Pharm Llc Treatment of cancer with tor kinase inhibitors.
WO2013075084A1 (en) 2011-11-18 2013-05-23 Constellation Pharmaceuticals Modulators of methyl modifying enzymes, compositions and uses thereof
WO2013075083A1 (en) 2011-11-18 2013-05-23 Constellation Pharmaceuticals Modulators of methyl modifying enzymes, compositions and uses thereof
NZ625511A (en) 2011-12-02 2016-03-31 Signal Pharm Llc Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
JP5989805B2 (en) 2012-02-10 2016-09-07 コンステレーション・ファーマシューティカルズ・インコーポレイテッドConstellation Pharmaceuticals,Inc. Methyl group-modifying enzyme regulator, composition and use thereof
US8865716B2 (en) 2012-02-23 2014-10-21 Boehringer Ingelheim International Gmbh Dihydropteridinones II
US9006226B2 (en) 2012-02-23 2015-04-14 Boehringer Ingelheim International Gmbh Dihydropteridinones I
KR102064626B1 (en) 2012-02-24 2020-01-09 시그날 파마소티칼 엘엘씨 Methods for treating non-small cell lung cancer using tor kinase inhibitor combination therapy
AU2013203714B2 (en) 2012-10-18 2015-12-03 Signal Pharmaceuticals, Llc Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity
JP2016505041A (en) 2013-01-16 2016-02-18 シグナル ファーマシューティカルズ,エルエルシー Substituted pyrrolopyrimidine compounds, compositions thereof, and therapeutic methods using them
EP2958918B1 (en) * 2013-02-21 2016-12-07 Boehringer Ingelheim International GmbH Dihydropteridinones ii
EP2958919B1 (en) * 2013-02-21 2019-05-22 Boehringer Ingelheim International GmbH Dihydropteridinones i
EP2970305B1 (en) 2013-03-15 2017-02-22 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
US9359364B2 (en) 2013-04-17 2016-06-07 Signal Pharmaceuticals, Llc Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one
NZ629469A (en) 2013-04-17 2017-05-26 Signal Pharm Llc Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
BR112015026021A2 (en) 2013-04-17 2017-07-25 Signal Pharm Llc combination therapy comprising a tor kinase inhibitor and n- (3- (5-fluoro-2- (4- (2-methoxyethoxy) phenylamino) pyrimidin-4-ylamino) phenyl) acrylamide for cancer treatment
EP2986322A1 (en) 2013-04-17 2016-02-24 Signal Pharmaceuticals, LLC Combination therapy comprising a tor kinase inhibitor and a 5-substituted quinazolinone compound for treating cancer
CN105377260A (en) 2013-04-17 2016-03-02 西格诺药品有限公司 Treatment of cancer with dihydropyrazino-pyrazines
MX2015014599A (en) 2013-04-17 2016-03-03 Signal Pharm Llc Combination therapy comprising a tor kinase inhibitor and a cytidine analog for treating cancer.
KR20160007502A (en) 2013-04-17 2016-01-20 시그날 파마소티칼 엘엘씨 Treatment of cancer with dihydropyrazino-pyrazines
CN109503591A (en) 2013-05-29 2019-03-22 西格诺药品有限公司 Pharmaceutical composition, its solid form and their purposes of dihydro pyrazine and pyrazine compound
ES2635003T3 (en) * 2013-07-09 2017-10-02 Bayer Pharma Aktiengesellschaft Dihydroquinoxalinones and dihydropyrididopyrazinones modified BET protein inhibitors
US9975896B2 (en) 2013-07-25 2018-05-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
EP3024464A1 (en) 2013-07-26 2016-06-01 Boehringer Ingelheim International GmbH Treatment of myelodysplastic syndrome
US9969716B2 (en) 2013-08-15 2018-05-15 Constellation Pharmaceuticals, Inc. Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof
CN103664845B (en) * 2013-12-27 2016-02-10 湖南欧亚生物有限公司 The preparation method of amino-2, the 3-Dihydrobenzofuranes-4-formic acid of a kind of Plk kinase inhibitor drug intermediate 7-
JP2017504653A (en) 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド Diaminopyrimidine benzenesulfone derivatives and uses thereof
US20160347750A1 (en) * 2014-01-31 2016-12-01 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
NZ629860A (en) 2014-04-16 2016-01-29 Signal Pharm Llc Methods for treating cancer using tor kinase inhibitor combination therapy
NZ629877A (en) 2014-04-16 2015-12-24 Signal Pharm Llc Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
NZ629884A (en) 2014-04-16 2016-03-31 Signal Pharm Llc Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, and a coformer, compositions and methods of use thereof
NZ629866A (en) 2014-04-16 2015-12-24 Signal Pharm Llc Solid forms comprising 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, and a coformer, compositions and methods of use thereof
WO2015193228A1 (en) * 2014-06-19 2015-12-23 Bayer Pharma Aktiengesellschaft Bet-protein inhibiting 1,4-dihydropyrido[3,4-b]pyrazinones with para-substituted aromatic amino- or ether groups
WO2015193229A1 (en) * 2014-06-19 2015-12-23 Bayer Pharma Aktiengesellschaft Bet-protein inhibiting 1,4-dihydropyrido[3,4-b]pyrazinones with meta-substituted aromatic amino- or ether groups
NZ629796A (en) 2014-07-14 2015-12-24 Signal Pharm Llc Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
EA201790189A1 (en) 2014-07-14 2017-11-30 СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Methods of treating malignant numer formation using substituted pyrropyrymidin compounds, compositions on their basis
WO2016022902A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
MX2017003288A (en) 2014-09-16 2017-06-28 Gilead Sciences Inc Methods of preparing toll-like receptor modulators.
CN106715431A (en) 2014-09-16 2017-05-24 吉利德科学公司 Solid forms of a toll-like receptor modulator
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
US10577350B2 (en) 2015-08-28 2020-03-03 Constellation Pharmaceuticals, Inc. Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
DE102017005091A1 (en) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituted 3,4-dihydropyrido [2,3-b] pyrazine-2 (1H) -one
DE102017005089A1 (en) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituted 3,4-dihydroquinoxaline-2 (1H) -one
CN109843870A (en) 2016-10-19 2019-06-04 星座制药公司 The synthesis of EZH2 inhibitor
WO2019126696A1 (en) * 2017-12-22 2019-06-27 Dana-Farber Cancer Institute, Inc. Nek inhibitors and methods of use
WO2019209757A1 (en) * 2018-04-24 2019-10-31 Vertex Pharmaceuticals Incorporated Pteridinone compounds and uses thereof
CN108610343A (en) * 2018-06-12 2018-10-02 杨文思 A kind of epidermal growth factor receptor inhibitor and its synthetic method for treating cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645152B1 (en) * 1989-03-30 1991-05-31 Lipha 3h-pteridinones-4, methods of making and medicaments containing them
CA2029651C (en) * 1989-11-17 2000-06-06 David D. Davey Tricyclic pteridinones and a process for their preparation
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
KR20020027649A (en) * 1999-09-15 2002-04-13 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Pteridinones as Kinase Inhibitors
WO2002076954A1 (en) * 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases

Also Published As

Publication number Publication date
AU2002337047B8 (en) 2003-03-18
JP3876254B2 (en) 2007-01-31
AR036586A1 (en) 2004-09-22
EP1427730B1 (en) 2006-07-12
MY129751A (en) 2007-04-30
WO2003020722A1 (en) 2003-03-13
CA2458699A1 (en) 2003-03-13
BRPI0212137A2 (en) 2016-06-28
MXPA04002067A (en) 2004-06-07
UA76512C2 (en) 2004-07-15
YU27304A (en) 2006-08-17
DE50207522D1 (en) 2006-08-24
NO328804B1 (en) 2010-05-18
DK1427730T3 (en) 2006-11-06
KR20040029465A (en) 2004-04-06
EA007062B1 (en) 2006-06-30
AU2002337047B2 (en) 2008-01-10
IL160440A (en) 2009-09-01
HU0401293A3 (en) 2008-03-28
HRP20040213A2 (en) 2005-02-28
AT332898T (en) 2006-08-15
NO20040680D0 (en) 2004-02-16
CA2458699C (en) 2010-10-19
JP2005501904A (en) 2005-01-20
EP1427730A1 (en) 2004-06-16
PL369740A1 (en) 2005-05-02
ES2268093T3 (en) 2007-03-16
CN1551881A (en) 2004-12-01
NO20040680L (en) 2004-02-16
IL160440D0 (en) 2004-07-25
KR100955589B1 (en) 2010-04-30
NZ531928A (en) 2005-10-28
HU0401293A2 (en) 2004-10-28
UY27427A1 (en) 2003-03-31
RS51012B (en) 2010-10-31
PT1427730E (en) 2006-11-30
EA200400368A1 (en) 2004-12-30
CO5560575A2 (en) 2005-09-30
ECSP045003A (en) 2004-04-28

Similar Documents

Publication Publication Date Title
HK1167332A1 (en) Pharmaceutical composition, use thereof and method for making the same
DE60103508D1 (en) Pyrrolopyrimidinone derivatives, method for the production and use thereof
DE59813983D1 (en) Substituted 2-aryl-4-amino-chinazolines, method for the production thereof and their use as medicaments
DE60323936D1 (en) Bioabeaable polycetales, method for the production thereof, and their use
CA2423285A1 (en) Polyammonium-polysiloxane compounds, methods for the production and use thereof
ZA200403064B (en) 1,6 naphthyridine derivatives antidiabetics
DE60228846D1 (en) New mesogenes, method for their production and use
ZA200308350B (en) Novel 4-anilinoquinoline-3-carboxamides.
PL367705A1 (en) Polyurethane elastomers, method for the production thereof and their use
ZA200200609B (en) Process for producing phenyl-alkanes compositions produced thereform, and uses thereof.
ZA200506369B (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
HRP20040149A2 (en) Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
HU0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
DE60025243D1 (en) Pyrimidin-5-carboximide compounds, method for the production thereof and their use
AU2002354267A1 (en) Polyketone and process for producing the same
MXPA03007349A (en) Xanthine derivative, production and use thereof as a medicament.
DE60223699D1 (en) Diarylsulfidderivat, dessen additionssalz und immunsuppressivum
SI1555267T1 (en) 2,3-DIHYDRO-6-NITROIMIDAZOS2,1-bCOXAZOLES
AU2002334135A1 (en) Antibodies against KDR, their production and uses
ZA200305498B (en) Xanthine derivative, production and use thereof as a medicament.
ZA200307322B (en) 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity.
IL168238A (en) Modifled biological substance, process for producing the same and intermediate
RU2004101409A (en) Spiro- and dispiro-1, 2, 4-trioxolane anti-malarian medicines
ZA200307218B (en) 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity.
IL166623A (en) Aripiprazole complex, formulations comprising the same and uses thereof